In vitro packaging of SV40: a pseudoviral gene delivery system

Summary

Nuclear extracts from baculovirus-infected insect cells of the meadow moth (Sf9 ) encode the major capsid protein (V P l ) of simian virus 40 (S V 4 0 ). In the presence of M g C l 2 , CaCl2 and A T P , these nuclear extracts were able to package the superhelical structure of the plasmid D N A or R N A scrambled (R N A i ) sequences, resulting in the formation of S V 40 pseudovirosomes in vitro. This packaging method has many advantages over other viral or nonviral delivery systems. In particular, it has a wide host range and a high conversion rate. The only disadvantage of this system is the low expression per transformed cell observed in vitro , probably due to the fact that the produced D N A is confined to the cytoplasm and cannot enter the nucleus. Author: T. Friedman et al, Translated by W. Jing et al. This experiment is from "Gene Transfer".

Operation method

S V 4 0 In Vitro Delivery System

Move

S V 4 0 In Vitro Delivery System Materials

reagents

A T P (10 0 m m o l/ L; R oche)

Buffer I

10 m m o l/L H E P E S (p H 7. 9)

10 m m o l/L K C l

0.lm m o l/L E D T A

0 . 1 m m ol/L E G T A

Sterilize by filtration with a 0.22um membrane. Buffer I can be stored at 4°C for 30d.

Add before use:
0.5 m m o l / L phenylmethylsulfonyl fluoride (P M S F )

l m m o l / L dithiothreitol (D T T )

Dissolve 1 tablet of protease inhibitor (Roche 1873580 ) in Iml PBS and dilute with buffer I 1 :50.

Buffer II

20m m o l / L H E P E S ( p H 7. 9)

0.4 m m o l / L NaCl

0.l m m o l / L E D T A

l m m o l / L E G T A

Sterilize by filtration with a 0.22um membrane. Buffer II can be stored at 4°C for 30 days.

Add before use:

l m m o l / L P M S F

l m m o l / L D T T

Dissolve 1 tablet of protease inhibitor (Roche 1873580 ) in Iml PBS and dilute with buffer 11:50

CaCl2 (10 mmol/L)

Cells

Cell lines used for research

Cell lines to be transformed are maintained in Petri dishes or suspension.

Grassland nightshade moth (Sf9 ) cells

Medium

Cell growth medium (G r a c e insect culture with whey protein and yeastolate)

Complete generation medium

Use the appropriate medium for the cell line under study.

M g C l 2 (200m m o l /L )

Nonidet P-40 (N P-40; 1 0% V/V in P B S )

Phosphate buffer (P B S )

Plasmid D N A (up to 17. 7k b)

To obtain the highest in vitro loading efficiency, plasmid D N A was purified by equilibrium centrifugation using a density gradient of C s C l - cesium chloride.

Small Interference RNA (s i RNA )

V P l Rodentivirus

VPl was cloned by eliciting a DNA fragment (1463^~2770 on SV40) into the pVL1393 plasmid (PharMingen, San Diego, California), which is derived from the Aw ton ra Can a cW/omicanuclear pholyhedrosis virus (AcMNPV) (Luckow and Summers 1988). PharMingen, San Diego, California) for VPl cloning (PharMingen, San Diego, California).
California). It was then digested by restriction endonucleases SmaI and BgZII (Sandalon and Opperiheim 1997, 2001). Virus reservoirs were dispensed and stored at 80°C.

Instrumentation

Incubator (constant humidity, 37°C, 5 % CO2)

Centrifuge tubes (40 ml, sterile, Sorvall)

Microcentrifuge tubes (1.5 ml)

Shaker

Stirred culture bottle (250m l )

Tissue Culture Dish (60m m )

Vortex mixer with microcentrifuge tube platform

Constant temperature water bath (37°C)

Methods

Transformed Sf9 cells

1. Freshly cultured 5 X 108 Sf9 cells were infected with V P l baculovirus at an infection multiplicity of 1 0 in 250 m l culture flasks.

Scaling up to 500 ml is not recommended.

Nucleoprotein extraction

Sf9 cells were collected 4~5d after infection. The time of cell harvesting is determined by the expression level of vpl and the packaging function of the nuclear extract.

2- Transfer the transformed cells from 250m l culture flasks to pre-cooled 40m l test tubes.

3-Prepare Buffers I and II. place on ice. Pre-cool microcentrifuge tubes.

4. Wash cells three times with cold PBS, centrifuging at 6000 rpm at 4°C for 5 millimeters each time.

5 - Remove supernatant. Vortex to completely resuspend the precipitate

Do not freeze this step.

6 - Add I m l of Buffer I. Gently blow to resuspend the precipitate until it is completely dispersed.

7- Slowly add 28 m l of Buffer I. Incubate on ice for 15 m i n .

8- Add 2. 3m l of 10% NP-40. vortex for 10s.

9-Centrifuge at 13,000r/m i n a refrigerated centrifuge (~4°C) for 3m i n .

10- Remove the supernatant with a pipette tip attached to a vacuum aspirator. The supernatant is removed with a pipette attached to a vacuum aspirator.

11 - Vortex the precipitate. Add 5 m l of Buffer II. Mix thoroughly and transfer to a microcentrifuge tube.

The total volume of each tube should exceed 1 ml.

I2. Place the tubes on the platform attached to the oscillator. Vortex at 4°C to mix for 15m i n .

13.4 C, 13 000r/m i n Centrifuge microcentrifuge tube for 5m i n .

14- Dispense the nuclear extract supernatant into pre-cooled tubes.

15- Determine the protein concentration of the nuclear extract.

Notice that the nuclear extract contains N P -4 ○. Not all methods for determining protein concentration are compatible with N 1m o . It can only be used for in vitro packaging if the concentration is greater than 3m g/m l.

16- Store nuclear extracts at 20 to 8 °C.
体外包装 17•对于每个反应的体外包装混合液,在 微 量 离 心 管 中 加 入 24y 200mm〇 l/L MgCl2、 30M1 100mmol/L A T P 和 IOOfXg从 V Pl-转化细胞中得到的核提取物。 18•加人 IOOpg 质粒 DNA 或 I^g siRNA。 体外包装反应的对照应是无核提取物的反应、从 未 转 化 的 Sf9 细胞得到的核提取物的反应 或 报 道 基 因 D N A 。 19. 加人双蒸水到总体积600/J 。充分混合。 20. 37°C水浴孵育6h。 21. 加 人 66/J 10mmol/L CaCl2 到每个反应管中。轻轻祸旋混合。 22. 在冰上孵育lh 。 23. 在一20°C保存体外包装反应管直到使用。 使 用 SV4 0 体外包装转化细胞 对原来的实验步骤所做的一些改变可以同时提高在几种细胞系的表达水平和转化效 率 (表 2)。 表 2 . 增加到原来实验方法里能提高表达量和转化率的步骤 体 外 准 备 在 步 骤 1 9 之 前 加 人 0 •3mmol/L 谷胱甘肽二硫化物和3mmol/L 还原型谷胱甘肽 包 装 反 应 在 转 化 之 前 ,用 〇 •1 单 位 的 DNase I 消 化 0 •0 1 个体外包装反应液30min后马上放到冰上 细 胞 转 化 转 化 前 5d,在细胞里加人0. 5ng/m l佛波酯(phorbol 12-myristate 13-acetate) 长期表达可以通过选择,转 化 后 24〜48h 就可以开始使用药剂,如 对 于 新 霉 素 使 用TOOpg/ml G418, 使 用 60; ig /m l的秋水仙素 使用相同的方法在第一次转化24h 后再次转化细胞 使用两个原来反应的体外载体(步骤14)用微量浓缩过滤系统浓缩成一个反应的体积(Centricon离 心过滤系统体积至少2ml,YM-100 w•膜Millipore) 转 化 前 加 人 IOngAnl的组蛋白去乙酰化抑制剂T S A 到细胞中 24.转 化 前 16〜24h,用胰酶消化贴壁生长的所需细胞系。 25•转移细胞到60m m 组织培养皿,密度为每盘I X l O 5 个细胞。 如果细胞是悬浮生长,每 个 6 0 _ 培养皿中加入 I X l O 5 个细胞,总 体 积 340fj 。 26•加人5ml完全培养基。在 37°C , 5 % C0 2 恒湿培养箱中孵育。 27•解冻体外包装反应管(步 骤 23)。每个盘中加人一管体外包装反应液。 用经裸露D N A 转化的细胞作为对照。 2 8 . 把盘子放在位于培养箱内的摇床上。摇 2. 5h 。 29. 加 入 4m l新鲜的完全生成培养基到每个盘中。然后放回到培养箱里。 30. 2 4 h 后或转化后更长时间计算基因表达量和功能。


For more product details, please visit Aladdin Scientific website.

https://www.aladdinsci.com/

Categories: Protocols

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.